Metraipolis › archive › dc_51430e40d02f
Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic — Europe PMC PMID:40830930
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40830930
- DOI
- 10.1186/s12879-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:38:52.429Z
- SHA-256 of the archived text
32f15b1ed42768abcb5d3bfc2006350ff680b6d0566b556b9cddc94de225ecb3- Stable URL of this page
https://metraipolis.com/documento/dc_51430e40d02f
How to cite
Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic — Europe PMC PMID:40830930 — Europe PMC (en), https://europepmc.org/article/MED/40830930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_51430e40d02f (Metraipolis archive dc_51430e40d02f, sha256 32f15b1ed42768abcb5d3bfc2006350ff680b6d0566b556b9cddc94de225ecb3)
BibTeX
@misc{dc51430e40d02f,
title = {Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic — Europe PMC PMID:40830930},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40830930},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_51430e40d02f; sha256 32f15b1ed42768abcb5d3bfc2006350ff680b6d0566b556b9cddc94de225ecb3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40830930. Agents can read the archived copy with the MCP tool read_document.